Peyronie Disease
📧 Sign up to get email alerts when something new happens for Peyronie Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-06-09FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) submitted by Endo USA, Inc., representing an …
-
FDA approval · 2021-04-13FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Xiaflex (collagenase clostridium histolyticum) submitted by Endo USA, Inc. The approval expands …
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: Xiaflex® Plus Testosterone Treatment Pilot Study Protocol [Phase 4]
Phase 4 pilot study protocol update evaluating Xiaflex with testosterone treatment for Peyronie's Disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: H-22411: BOTOX® for Peyronie's Disease [Phase 2]
Phase 2 clinical trial update for BOTOX for Peyronie's Disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response [Phase 4]
Phase 4 clinical trial update evaluating additional Xiaflex treatment in patients with Peyronie's Disease who have recurrence, worsening, or…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease
Long-term safety, curvature deformity characterization, and immunogenicity over time in subjects previously treated with AA4500 for Peyronie…
-
FDA approval · 2018-06-06FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) filed by Endo USA, Inc.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease [Phase 1]
A Phase 1 trial comparing testosterone pellets plus vitamins D and E versus vitamins D and E alone for Peyronie's disease has completed, pro…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease [Phase 3]
This update reports on the completion of a Phase 3 open-label study evaluating AA4500 in combination with the ErecAid Esteem manual vacuum t…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Outcomes of Surgical Correction of Penile Curvature in Adult
This clinical trial update covers outcomes after surgical correction of penile curvature in adult patients. The current study status is unkn…
-
FDA approval · 2016-11-28FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) from Endo USA, Inc., marking an approved update t…
-
FDA approval · 2016-09-19FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) from Endo USA, Inc., indicating an approval relat…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease [Phase 2]
Phase 2 trial update on pharmacokinetics of a single treatment cycle of AA4500 0.58 mg in men with Peyronie's Disease; study completed with …
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: A Study of AA4500 in Men With Peyronie's Disease [Phase 3]
Phase 3 trial update for AA4500 in men with Peyronie's disease; study completed with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-04-10Clinical Trial Update: Management of Peyronie's Disease With Adipose Tissue Stem Cell [NA]
Clinical trial evaluating adipose tissue stem cells for Peyronie's disease and erectile dysfunction; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Study of AA4500 in the Treatment of Peyronie's Disease [Phase 3]
Phase 3 trial of AA4500 for Peyronie's disease completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Study of AA4500 in the Treatment of Peyronie's Disease [Phase 3]
Phase 3 clinical trial of AA4500 for Peyronie's Disease completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease [Phase 3]
Phase 3 open-label trial evaluating AA4500 given in two monthly doses per cycle over up to four cycles for Peyronie's disease; study complet…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD [Phase 1]
Phase 1 trial evaluating the safety and feasibility of injecting PMD-MSC into the penis to treat Peyronie's disease; the study status is com…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Peyronie's Disease Treatment Protocol [Phase 1]
Phase 1 clinical trial update on a Peyronie's Disease treatment protocol; the study has completed.
-
FDA approval · 2012-02-24FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) by Endo USA, Inc., marking an update to the p…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease [Phase 2]
Phase 2 trial update assessing safety and effectiveness of AA4500 in Peyronie's disease; results posted after completion.